Great news for Moderna holders, the market at large, and the public in general!
In the trial, each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine.
ALL GROUPS SHOWED INCREASED IN ANTIBODIES.
Phase 3 of testing is starting later this month. It's nice to have a very promising vaccine in the pipeline.
This could cause the market as a whole to have a big day tomorrow, keep your eyes on the airlines and cruise stocks imo. But yeah could be very good news across the board.
Submitted July 14, 2020 at 05:37PM by RCnoob69 https://ift.tt/3j4Y5YE
